WSJ’s blog on health and the business of health. If a helix spirals in the same direction as the fingers on the right hand are pointing, then it is a right-handed helix (right). The reverse is true for a left-handed helix (left). Always more ...
WSJ’s blog on health and the business of health. In Genentech’s backyard yesterday, Roche sought to squelch skeptics of its $45 billion bid to acquire the chunk of the biotech giant it doesnt already own. Sure, there’s a global financial crisis and ...
Jamie Dimon, CEO of J.P. Morgan Chase, spends most of his time these days dealing what he calls the “calamity in our financial markets,” but he took a moment at his company’s big health-care investors conference today to stick his toe in another crisis ...
Roche’s blockbuster bid for the portion of Genentech it doesn’t own has stalled amid the credit crisis and stock market plunge, and concern persists over the impact of the proposed transaction on the biotech pioneer’s culture and productivity. Not to ...
As the American Heart Association scientific meeting wound down in New Orleans yesterday, Merck and Schering-Plough were braced for another hit to their joint cholesterol franchise medicines Vytorin and Zetia. The drugs — and especially the recently ...
Cardiologists are a data-hungry breed. And thousands of them found plenty to feed their habit as they streamed into a huge lecture hall at the American Heart Association’s annual scientific meeting today to hear their colleague Paul Ridker of Brigham ...
Merck wants the world to know that when it comes to developing new drugs for cardiovascular disease, the company is in the fight for the long haul. At the American Heart Association’s annual scientific meeting underway now through Wednesday in New ...
How many Amgen sales reps does it take to sell a potential new blockbuster to primary care doctors? The easy answer is, a lot more than it takes to screw in a light bulb. But the biotech company is pondering the more serious question of how to launch ...
WSJ’s blog on health and the business of health. Here’s an unreality check to give some perspective of the carnage on Wall Street: The market cap of biotech upstart ImClone Systems is nearly double that of General Motors. GM, meantime, hit an ...
Perhaps no doctor is more linked to the rise of modern medicine - and certainly to the rise of modern heart surgery- than Michael E. DeBakey, the trailblazing Baylor cardiovascular surgeon who died late Friday at age 99. And as a surgeon, he treated ...
Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.